Gilead Hits Lupin With Patent Suit Over HIV Drug Atripla
Gilead Sciences Inc. has sued Lupin Ltd. in New York federal court, claiming the generic-drug maker infringed two patents covering its drug Atripla, a medication used to treat HIV patients....To view the full article, register now.
Already a subscriber? Click here to view full article